Survey: Are you ready for low-dose cannabidiol products?

Low-dose cannabidiol products will soon be available in pharmacies. Are Australian pharmacists ready? Researchers from the Lambert Initiative for Cannabinoid Therapeutics and the Sydney Pharmacy School at the University of Sydney are surveying pharmacists to identify attitudes towards, experiences with and education level on prescription medicinal cannabis and low-dose CBD. The Lambert Initiative team, led by pharmacist Zeeta Bawa,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next FIP steps up on diet, exercise